Chemical formula: C₆H₁₁NO₂ Molecular mass: 129.157 g/mol PubChem compound: 5665
Vigabatrin is indicated for:
Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)
Vigabatrin is indicated in infants and children from 1 month to less than 7 years of age for treatment in combination with other antiepileptic medicinal products for patients with resistant partial epilepsy (focal onset seizures) with or without secondary generalisation, that is where all other appropriate medicinal product combinations have proved inadequate or have not been tolerated.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old)
Kigabeq is indicated in infants and children from 1 month to less than 7 years of age for treatment in monotherapy of infantile spasms (West’s syndrome).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
Vigabatrin is indicated in infants and children from 1 month to less than 7 years of age for treatment in combination with other antiepileptic medicinal products for patients with resistant partial epilepsy (focal onset seizures) with or without secondary generalisation, that is where all other appropriate medicinal product combinations have proved inadequate or have not been tolerated.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Vigabatrin is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
